Ranbaxy Malaysia JV To Build $35 Million, 3 Billion-Dose Production Plant
This article was originally published in PharmAsia News
Executive Summary
A Ranbaxy Laboratories joint venture has selected an industrial park in Malaysia for constructing a $35 million manufacturing facility for dosage forms of heart, diabetes and gastrointestinal drugs.